Skip to content
10-Q

Quarterly Report

Veradermics, Inc MANE

0001827635-26-000019

← back to feed
Filed
May 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 7, 2026 41.78M sh
Shares Diluted Q1 2026 · Mar 31, 2026 22.7M sh
Shares Diluted Q1 2026 · Mar 31, 2025 736.93K sh
Capex Q1 2026 · Mar 31, 2026 $0
Capex Q1 2026 · Mar 31, 2025 $19K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$21.17M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$13.32M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $168.41M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $21.77M
Stockholders Equity Q1 2026 · Mar 31, 2026 $390.64M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$121.01M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$60.67M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$48.48M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.72M
Current Liabilities Q1 2026 · Dec 31, 2025 $9.15M
Total Liabilities Q1 2026 · Mar 31, 2026 $6.72M
Total Liabilities Q1 2026 · Dec 31, 2025 $9.16M
Current Assets Q1 2026 · Mar 31, 2026 $397.07M
Current Assets Q1 2026 · Dec 31, 2025 $152.49M
Total Assets Q1 2026 · Mar 31, 2026 $397.36M
Total Assets Q1 2026 · Dec 31, 2025 $152.62M
Eps Diluted Q1 2026 · Mar 31, 2026 −$1.32
Eps Diluted Q1 2026 · Mar 31, 2025 −$19.79
Eps Basic Q1 2026 · Mar 31, 2026 −$1.32
Eps Basic Q1 2026 · Mar 31, 2025 −$19.79
Sga Expense Q1 2026 · Mar 31, 2026 $8.94M
Sga Expense Q1 2026 · Mar 31, 2025 $1.47M
Rd Expense Q1 2026 · Mar 31, 2026 $20.93M
Rd Expense Q1 2026 · Mar 31, 2025 $11.45M
Net Income Q1 2026 · Mar 31, 2026 −$27.23M
Net Income Q1 2026 · Mar 31, 2025 −$12.4M
Operating Income Q1 2026 · Mar 31, 2026 −$29.86M
Operating Income Q1 2026 · Mar 31, 2025 −$12.92M